Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Alienor Xhaard, MD, Constance Xhaard, Maud D'Aveni, MD, Hélène Salvator, MD PhD, Marie-Laure Chabi-Charvillat, MD, Tereza Coman, MD PhD, Yves Beguin, MD PhD, Yves Chalandon, MD, Xavier Poire, MD, Michael Loschi, MD PhD, Catherine Paillard, MD PhD, Bénédicte Bruno, MD, Patrice Ceballos, MD PhD, Jean-Hugues Dalle, MD PhD, Karin Bilger, MD, Jacques-Olivier Bay, MD PhD, Marie Robin, MD PhD, Stephanie N'guyen-Quoc, MD PhD, Marie Thérèse Rubio, MD PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-138411

Published: 2020

Journal Articles

Serotonin Targeting Using Common Antidepressants Induces Rapid Recovery of Cytopenia

Tereza Coman, MD PhD, Guillemette Fouquet, Julien Rossignol, MD PhD, Jean-Henri Bourhis, Olivier Hermine, Francine Côté, PhD

Blood (2019) 134 (Supplement_1): 3715.

https://doi.org/10.1182/blood-2019-122658

Published: 2019

Journal Articles

The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

Riwa Sakr, MD, Sylvain Pilorge, MD, Stephane De Botton, Claude Chahine, MD, Tereza Coman, MD PhD, Marcel Adler, MD, Jean-Baptiste Micol, MD PhD, Florence Pasquier, MD PhD, Christophe Willekens, MD, Alina Danu, MD, Julien Lazarovici, MD, David Ghez, MD PhD, Eric Solary, MD, Vincent Ribbag, Jean-Henri Bourhis, Cristina Castilla-LLorente, MD PhD

Blood (2017) 130 (Supplement 1): 5544.

https://doi.org/10.1182/blood.V130.Suppl_1.5544.5544

Published: 2017

Journal Articles

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Alienor Xhaard, MD, Renato Cunha, MD PhD, Marc Busson, Marie Robin, MD PhD, Nathalie Dhedin, MD, Tereza Coman, MD PhD, Aurelie Cabannes-Hamy, MD, Flore Sicre de Fontbrune, MD, David Michonneau, MD PhD, Gerard Socie, MD PhD, Rodrigo T. Calado, MD PhD, Regis Peffault De Latour, MD PhD

Blood (2016) 128 (22): 3478.

https://doi.org/10.1182/blood.V128.22.3478.3478

Published: 2016

Journal Articles

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Simona Pagliuca, MD, Antonio M Risitano, MD PhD, Sylvie Chevret, Flore Sicre de Fontbrune, MD, Alienor Xhaard, MD, Tereza Coman, MD PhD, David Michonneau, MD PhD, Serena Marotta, MD, Mathilde Ruggiu, Swann Bredin, Regis Peffault de Latour, MD PhD, Gérard Socié, MD PhD, Marie Robin, MD PhD

Blood (2016) 128 (22): 2285.

https://doi.org/10.1182/blood.V128.22.2285.2285

Published: 2016

Journal Articles

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Régis Peffault de Latour, MD, Sylvie Chevret, MD PhD, Annalisa Ruggeri, MD, Felipe Suarez, MD PhD, Laetitia Souchet, MD, David Michonneau, MD PhD, Flore Sicre de Fontbrune, Tereza Coman, MD PhD, Marie t Rubio, MDPhD, Stéphanie Nguyen, MD PhD, Mohamad Mohty, MD PhD, Gerard Socie, MD PhD

Blood (2016) 128 (22): 65.

https://doi.org/10.1182/blood.V128.22.65.65

Published: 2016

NARROW

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Serotonin Targeting Using Common Antidepressants Induces Rapid Recovery of Cytopenia

The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Email alerts

ASH Publications

American Society of Hematology

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Serotonin Targeting Using Common Antidepressants Induces Rapid Recovery of Cytopenia

The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only